Tata Investment Corporation · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
A cybersecurity incident at a top automotive client caused project delays from September. While systems are reportedly back to normal with positive customer conversations, the revenue impact may persist partially into Q3 before full normalization.
Q2's strong 6.8% growth was driven by large deal ramp-ups that will moderate in H2. The segment remains under stress from M&A activity and corporate restructuring among broadcasters and operators, making visibility low.
U.S. market continues to be muted for core automotive OEM business due to EV incentive withdrawals and emission norm relaxations causing portfolio resets. Legacy OEMs are delaying EV conversion programs, affecting R&D spending.
Healthcare segment declined 2.3% due to conclusion of regulatory/MDR programs. While management expressed confidence in H2 improvement and FY27 double-digit growth based on Bayer deal and new customer additions, near-term visibility remains limited.
